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Abstract 
Background: Many infectious pathogens can be transmitted from animals to humans and vice versa, or by animals 
(especially arthropods) to humans. Such diseases are called zoonotic and/or vector‑borne diseases. To control or 
prevent them, it is often recommended to target population reduction of host or vector species, through preventive 
culling or insecticide use for example. But these types of destructive interventions have shown several limits altering 
their efficiency, including acquired resistance of arthropods to insecticides, unpredicted change in the ecology of 
host populations, unexpected negative functional consequences on ecosystems, as well as economic embrittlement 
when livestock is concerned. An alternative pathway of action would be to rely on the functioning of ecosystems, and 
on their careful management, to regulate diseases and thus reduce their impact on human health. In this perspec‑
tive, a thorough evaluation of the conditions that can potentially promote such a positive regulation of infectious 
pathogens by ecosystems, and their efficiency, is needed. Here, we present the protocol of a systematic review that 
will evaluate the scientific evidence existing on potential links between ecosystem components or functions and 14 
vector‑borne and zoonotic diseases impacting human health.
Methods: We will search for studies that tested the effect of changes in (i) biological communities, and (ii) habitats 
and landscapes, on diseases. Scientific literature from 5 publication databases will be screened in a 3‑rounds pro‑
cess: title, abstract and full‑text screening. At each stage, articles will be either rejected or kept for the next round, 
depending on whether they fall in the exclusion or inclusion criteria. We will present results in two parts: a systematic 
map and a systematic review. The systematic map will present, for the 14 diseases, the number of publications, their 
geographical distribution, the type of ecosystem component/function they studied, as well as the host(s) in which 
epidemiological measurements have been performed. From this systematic map, we will identify groups of articles 
that allow for critical appraisal, i.e. groups of articles that studied the effect of the same ecosystem component/func‑
tion on the same disease. Only those articles will be included in the systematic review. The validity of these articles will 
be assessed by critical appraisal and presented as a narrative synthesis with confidence levels.
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Background
About 60% of all infectious diseases infecting humans 
also infect wild and/or domesticated animals [1]. They 
are known as zoonotic diseases. Some of them are vec-
tor-borne, i.e. their causal infectious agents are trans-
mitted by arthropods (mainly mosquitoes, ticks and 
sandflies). Zoonotic and vector-borne diseases are due to 
a variety of pathogens that can be viruses, bacteria and 
eukaryotes. They all have in common the presence of one 
or several animal species in their biological cycle. These 
species are parts of an ecosystem: they are embedded in 
a trophic network, they live, feed, reproduce in specific 
habitats or landscapes [2]. This leads to think that eco-
systems and landscapes are somehow, positively or nega-
tively, involved in human health [3, 4].
This idea might sound obvious and acceptable, but its 
integration in health policies, at national and interna-
tional levels, is quite new [5, 6]. For many decades, health 
plans aiming to reduce the impact of vector-borne dis-
eases on human health have been mainly focused toward 
chemical and physical anti-vectorial fight, i.e. destroying 
vectors and their habitats or micro-habitats [7]. When 
zoonotic diseases infecting livestock represent a signifi-
cant threat for the economy [8], crisis mitigation strate-
gies often rely on preventive culling of livestock or of wild 
hosts to stop the epizooty. France recently went through 
two epizootic events that illustrated this. Two cases of 
brucellosis detected in 2012, likely caused by contacts of 
cows with infected ibex (Capra ibex), led to the slaugh-
ter of 200 ibex in the Bargy mountains [9]. In 2016/2017, 
an epizooty of avian influenza in poultry farms led the 
authorities to order a 6-weeks swallowing period, and 
thus the preventive culling of several million of fowls 
[10].
But these methods have shown their limits. Concern-
ing the use of insecticides, the first cases of mosquitoes 
resistant to an insecticide were reported within 1  year 
after the first spraying campaigns [11, 12]. Since then, 
insecticide resistance of mosquitoes has spread so much 
that pyrethroid insecticides no longer kill mosquitoes in 
many places of Africa [13], and that 60 countries among 
the 78 included in the monitoring program of the WHO 
reported mosquito resistance to at least one insecticide 
molecule [14].
For zoonotic diseases, attempts to control an epi-
zooty through the culling of wild hosts can be totally 
inefficient. Field studies performed 1  year after the 
above-mentioned culling of ibex, showed that the prev-
alence of brucellosis in the infected ibex population had 
not been reduced. In fact, it had even increased in the 
younger individuals. Moreover, given that males from 
surrounding non-infected populations came to “fill the 
blanks” left by the culling, the risk to see the infection 
spread to other populations was considered as high 
[9]. Finally, massive preventive culling, such as the one 
performed in 2017 to stem avian influenza, have huge 
socio-economical costs, without mentioning the ethi-
cal questions raised by the culling of millions of healthy 
animals. Sociological studies performed in Great Brit-
ain to evaluate citizens’ opinions regarding the cull-
ing of badgers to control bovine tuberculosis showed 
a large disapproval of this type of destructive control 
methods [15]. These limits highlight the need for alter-
native control methods that would no longer be based 
on the direct destruction of populations or habitats, 
but rather on the regulation functions performed by 
ecosystems.
Several mechanisms have been described to explain 
how natural changes in species richness and abundance 
can regulate certain diseases. Among them, the dilution 
effect has been particularly studied and debated [16–20]. 
It states that, in an ecosystem with a rich host commu-
nity, a pathogen would have a lower probability to find a 
highly competent host, i.e. a host in which it could mul-
tiply and, for a vector-borne disease, be transmitted to a 
suitable vector [21]. Several ecological conditions neces-
sary for this dilution effect to occur have been proposed 
by Ostfeld and Keesing [21, 22]. One of them is the nec-
essary tolerance of highly competent host species to per-
turbations, that enable them to become dominant while 
other species, less competent, decline. Such tolerance 
to perturbation has been reported for the white-footed 
mouse Peromyscus leucopus, a highly competent host for 
Lyme disease [23], and the American robin Turdus amer-
icanus, a highly competent host for the West Nile virus 
[24, 25]. A meta-analysis performed on 345 wetlands by 
Johnson et  al. [26] found that host species highly com-
petent for the parasite Ribeiroia ondatrae, responsible 
for amphibian limb malformations, dominate in species-
poor communities, while richer communities contain 
more low-competent species, which decreases the overall 
host competence in the ecosystem.
Among dilution hosts, some species have a competence 
close to zero, and act as “ecological traps” for the patho-
gen or the vector. These species are sometimes referred 
to as “dead-end hosts”. This seems to be the case of the 
opossum Didelphis virginiana that kills the vast majority 
of ticks that attach to him [27]. It has also been reported 
for the roe deer Capreolus capreolus which has the ability 
to destroy in his bloodstream the spirochetes of Borrelia 
burgdorferi responsible for Lyme disease, thus preventing 
the infection of ticks that feed on roe deers [28]. How-
ever, the roe deer plays a key-role in the reproduction of 
Ixodes ticks, vectors of the Lyme disease agent [29], illus-
trating the complexity of interactions between diseases 
and ecosystems.
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Ecological competition between vector/host species 
and species that occupy the same ecological niche but are 
not a vector/host for the pathogen can a priori be seen as 
a form of dilution effect. However, an experimental study 
performed by Johnson et  al. [30] showed that increas-
ing the diversity of snails reduced transmission of schis-
tosomiasis, even when maintaining a constant density 
of the snail Biomphalaria glabrata, which was the only 
host of schistosomiasis- in the studied snail community. 
This result suggests a positive effect of host diversity that 
would not be mediated by a decrease in the density or 
abundance of the host.
The regulation of diseases can also occur through pre-
dation that can decrease populations of vectors or hosts 
[31–33]. However, some authors suggest that not all 
predators are equally efficient in this respect, and that 
generalist predators can regulate host or vector popula-
tions more efficiently than specialized ones [34].
The examination of these various mechanisms leads us 
to suggest that modifications of habitats or landscapes 
structure, including by appropriate management, could 
also lead to changes in diseases incidence, by changing 
vector or host populations, or altering/enhancing cer-
tain population dynamics. This would relate to services 
provided by the regulation function of ecosystems. For 
example, a growing proportion of grasslands in agricul-
tural landscapes has been shown to increase echinococ-
cosis, by favoring populations of intermediate hosts, 
grassland rodents [35], and increasing predation by the 
red fox Vulpes vulpes, the definitive host of echinococ-
cosis [36]. It is however interesting to notice that these 
ecological conditions, favorable to echinococcosis, would 
likely be unfavorable to other diseases such as Lyme dis-
ease. Indeed, in this case the red fox Vulpes vulpes is not 
a definitive host but acts at the contrary as a regulator of 
rodent hosts, thus potentially decreasing the incidence of 
the disease [32].
The links between the functioning of ecosystems, their 
modification, and infectious diseases are thus highly 
complex, and knowledge on these links is scattered and 
fragmented. This review has 2 main goals: first, to evalu-
ate how much evidence exists about the links between 
ecosystem components/functions and 14 vector-borne 
and zoonotic diseases impacting human health, as pre-
liminary scoping suggests that many knowledge gaps 
exist. Second, for diseases with existing relevant litera-
ture, the strength of those links will be appraised and 
synthesized.
Stakeholder engagement
This systematic review was commissioned by the French 
Ministry for the Ecological and Inclusive Transition, 
in the framework of the third National Action Plan for 
Health and Environment (2015–2019). The Ministry is 
accompanied by a working group of more than 15 stake-
holders (mostly scientifically-oriented) who initially pro-
posed a list of diseases to be assessed. The advancement 
of the mission is regularly reported to this group. The 
execution of the review was entrusted to the National 
Agency for Biodiversity (AFB) and the Foundation for 
Research on Biodiversity (FRB). The review team was 
initially composed of a core staff based in FRB/AFB and 
completed by a panel of experts. These experts were 
contacted upon consultation of the literature and upon 
suggestions made by the stakeholders. A total of 26 
French-speaking experts from public research institu-
tions or nature management agencies, working on the 5 
continents, have accepted to collaborate. They belong to 
various disciplines such as eco-epidemiology, ecology of 
pathogens, vectors or hosts. This panel group was associ-
ated to the elaboration of the protocol and will partici-
pate to the whole review process.
A steering committee validates decisions on the fram-
ing on the review, the diseases to include, the experts to 
associate, etc. It is composed of representatives from 4 
French ministries (Ecology, Health, Research, Agricul-
ture), from ANSES,1 and from the National Action Plan.
Objective of the review
In this systematic review, we will assess the links between 
ecosystems and 14 vector-borne and zoonotic infec-
tious diseases that have been identified by the French 
Ministry for Ecological and Inclusive Transition and the 
French Ministry for Health and Solidarities as causing, 
or susceptible to cause, a public health issue in France, 
including French Overseas Territories (cf. list below in 
“Definition of the question components”). These 14 dis-
eases cover a large range of types of pathogen organisms 
(virus, bacteria, protozoan, nematode), with variable 
life-cycle complexity (single host, multi-hosts, vector-
borne), and are linked to different types of ecosystems 
(aquatic, tropical forests, temperate forests, peri-urban, 
agricultural).
Our objective is double. First, produce a systematic 
map whose primary question will be “What knowledge 
exists on potential effects of ecosystem components or 
functions on the impact of vector-borne and zoonotic 
diseases?”. In this map, we aim to present, for 14 diseases, 
the existing knowledge in term, notably, of number of 
relevant articles and type of ecosystem function/compo-
nent studied. Second, conduct a systematic review on the 
subset of diseases for which existing literature allows for 
critical appraisal. The question of this systematic review 
1 French Agency for Food, Environmental and Occupational Health & Safety.
Page 4 of 11Lugassy et al. Environ Evid             (2019) 8:4 
will be: “What is the modifying effect of ecosystem com-
ponents or functions on the impact of vector-borne and 
zoonotic diseases?”.
Question definition and components
The map will address the question: “What knowledge 
exists on potential effects of ecosystem components or 
functions on the impact of vector-borne and zoonotic 
diseases?”
The synthesis will answer to the question: “What is the 
modifying effect of ecosystem components or functions 
on the impact of vector-borne and zoonotic diseases?”
The question components are detailed hereafter:
Population
Ecosystems, habitats, landscapes, or ecological commu-
nities in which the pathogen agent causing one of the 
14 selected diseases (i.e. leishmaniasis, schistosomiasis, 
Lyme disease, Malaria, dengue, chikungunya, Zika, West 
Nile disease, bovine tuberculosis, avian influenza, brucel-
losis, leptospirosis, echinococcosis, or cryptosporidiosis) 
is present.
Exposure/intervention
Any type of exposure/intervention susceptible to modify 
the biological cycle of the pathogen through modifica-
tions of habitats, landscapes, or ecological communities.
Comparator
Before/after an exposure/intervention; in space between 
habitats, ecosystems, or landscapes with different levels/
intensities of exposure or with/without intervention.
Outcome
Any change, at any scale, in the incidence, prevalence, 
intensity or transmission of the disease in humans and/or 
vectors and/or animal hosts infected by pathogen agents 
responsible for the 14 diseases listed above.
Methods
Searches
Search strategy
Our search strategy has been designed to retrieve arti-
cles that cover a broad range of ecosystem components/
functions and diseases. We will search for publications 
in 5 bibliographic databases, identified as relevant by the 
review team and the expert panel, and listed in “Biblio-
graphic databases”. In each database, we will perform one 
search per disease. We will search in the “topic” section 
or in the title/abstract/keywords, whenever this option 
is possible. These databases are either available in open-
access, or through a pre-existing subscription of FRB or 
research institutions of experts. Unpublished research 
articles will also be searched for, in an effort to minimize 
publication bias, and scientists from the expert panel and 
the enlarged committee have been asked to share unpub-
lished articles.
Grey literature will be collected, and we will put effort 
in collecting reports from local initiatives (through envi-
ronmental NGOs) or management practices (i.e. through 
national and regional natural parks). Institutional web-
sites will also be searched for grey literature (see details 
in “Organizational websites”), but because they rarely 
allow complex searches, we will only use disease names 
as search terms.
Search string
The search string has been built based on a scoping exer-
cise conducted on Web of Science in May–June 2018. 
This search string is structured into 3 elements related 
to Population and Outcomes. We chose not to use Inter-
vention- or Exposure-related search terms, as it seemed 
impossible to exhaustively list them and thus retrieve all 
the possible range of them.
The 1st element targets articles mentioning the 
required disease or pathogen agent(s). It is the only part 
of the search string that will differ between searches for 
different diseases. Synonyms of disease names, including 
vernacular names, were listed using the Mesh database 
and Google and will be included in the search string. This 
list can be found in Additional file 1, along with the list 
of pathogen agents identified for each disease. The 2nd 
element contains keywords related to the structure and 
the functioning of ecological communities. The 3rd ele-
ment contains altogether generalist keywords related to 
ecosystems or ecology (part 3a) and a list of habitat types 
(part 3b) in order to try retrieve specific field studies 
that do not mention the generalist keywords. This list of 
habitats has been built based on the habitat classification 
from UICN [37], from which we selected first-level habi-
tats relevant for the 14 diseases included in the review 
(i.e. all habitats except marine habitats, rocky areas and 
deserts) and added synonyms.
The 3 elements will be combined using the Boolean 
operators AND (both terms must be found) and OR (at 
least one term must appear), as follow: 1 AND 2 AND (3a 
OR 3b).
The operator NEAR/5 (both terms must appear, with 5 
words maximum between them) will be used inside the 
2nd element. The ‘*’ wildcard will allow to retrieve plu-
rals and words sharing the same root such as the words 
“predator”, “predation”, “predated” (etc.) from the single 
word predat*.
Detailed search string, as designed for the Web of Sci-
ence database: 
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(Name(s) of the disease OR name(s) of the pathogen 
agent(s)) AND
((species OR vector OR host OR community OR 
population OR prey) NEAR/5 (compos* OR struc-
tur* OR divers* OR densit* OR rich* OR abundan* 
OR dynamic* OR increas* OR decreas* OR chang* 
OR homogen* OR heterogen*)) AND
((land* OR habitat OR ecolog* OR ecosystem* OR 
predat* OR wildlife OR “wild life” or “wild ani-
mals” OR “wild fauna” OR biodiversity OR “dilution 
effect”) OR
(forest* OR shrub* OR scrub* OR wood* OR grass* 
OR pasture* OR arable* OR wetland OR peat* OR 
grove OR hedgerow OR mangrove OR savanna* OR 
bush OR bushes OR ricefield OR “rice fields” OR 
paddy OR plantation OR tundra OR pond OR canal 
OR ditch OR river OR stream OR creek OR bog OR 
marsh OR swamp OR fen OR lake OR oases OR 
delta OR mountain OR cave OR estuary OR dune 
OR lagoon OR island OR garden OR park OR “green 
areas”))
This search string was validated by the expert panel. It 
will be adapted to the specific requirements of each bib-
liographic database (Boolean operator accepted, maxi-
mum number of words). If it must be reduced, priority 
will be given to the 1st and 2nd elements of the search 
string. The search string used in each database will be 
reported in an Additional file attached to the system-
atic review to ensure replicability and facilitate future 
upgrading.
Language
For most diseases, we will search for literature written 
in English and in French. This should allow to screen 
most of the peer-reviewed scientific literature as well as 
research published in French and adapted to the French 
context. For leishmaniasis and schistosomiasis, two dis-
eases that marginally affect mainland France, but that are 
a major concern in French Guyana and French Caribbean 
islands, we will also search for literature in Spanish, to 
include studies performed in south/central America and 
in the Caribbean islands.
The potential sources of grey literature that we identi-
fied are either international institutions, or French insti-
tutions, so we will perform the search in English and 
French.
Bibliographic databases
Publications will be collected from the following 
databases:
• OpenGrey
• PubMed
• Science Direct
• Scopus
• Web of Science Core Collection
Web‑based search engines
Internet searches were used only at the scoping stage, to 
start building the test-lists. We limited our search to the 
results contained in the first 3 pages in:
• Google scholar (https ://www.schol ar.googl e.com)
• Google (https ://www.googl e.com)
Organizational websites
The 13 organizations whose websites will be searched are 
listed below:
• World Health Organization (https ://www.who.int)
• World Organization for Animal Health (https ://www.
oie.int)
• Centers for Disease Control and Prevention (https ://
www.cdc.gov)
• European Center for Disease Prevention and Control 
(https ://www.ecdc.europ a.eu)
• EcoHealth (https ://www.ecohe altha llian ce.org)
• European Commission for Environment (https ://
www.ec.europ a.eu/envir onmen t/index _en.htm)
• Food and Agriculture Organization (https ://www.fao.
org)
• French Ministry for the Ecological and Inclusive 
Transition (https ://www.ecolo gique -solid aire.gouv.fr)
• French Ministry for Solidarity and Health (https ://
www.socia l-sante .gouv.fr)
• French Ministry for Agriculture and Alimentation 
(https ://www.agric ultur e.gouv.fr)
• National Agency for Sanitary Security of Food, Envi-
ronment and Work (https ://www.anses .fr)
• Public Health France (https ://www.invs.publi quefr 
ance.fr)
• National Office for Hunting and Wild Fauna (http://
www.oncfs .gouv.fr)
Estimating the comprehensiveness of the search
To evaluate the performance of our search (see Addi-
tional file 2), we used test-lists built by the expert panel 
and the project leader. These test-lists are composed of 
articles identified as key-articles by the expert panel or 
by the review team, and collected using personal knowl-
edge, private bibliographic files, searches on Google and 
Google scholar. Relevant reviews identified were not 
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included in the test-lists, but the bibliographic references 
they contained were investigated to find other key-arti-
cles, using the snow-balling method.
For 5 of the 14 diseases, the number of relevant arti-
cles initially found ranged between 22 and 4, respectively 
for Lyme disease (n = 22), West Nile virus (n = 15), echi-
nococcosis (n = 12), schistosomiasis (n = 6) and malaria 
(n = 4). The number of articles from these 5 test-lists 
retrieved by our bibliographic search are reported in 
Additional file 2.
For the other diseases, we were either not able to iden-
tify any relevant article (cryptosporidiosis, leishmaniasis, 
avian influenza, Zika, bovine tuberculosis), only 1 article 
(Chikungunya, dengue virus, brucellosis) or only 2 arti-
cles (leptospirosis). This quasi-emptiness of 9 test-lists is 
likely to reflect the scarcity of existing literature on what 
is a quite new research topic for many diseases. The non-
empty test-lists can be consulted in the Additional file 2.
Search update
We will provide the date of the searches performed in 
each database as well as the exact search string to facili-
tate a future upgrading of the work.
Given that we will present both a systematic map and a 
systematic review, the subsequent part of this protocol is 
divided in two: the sections “Article screening and study 
inclusion criteria”, “Study validity assessment”, “Data cod-
ing strategy”, “Study mapping and presentation” detail the 
protocol for the systematic map, and the sections “Study 
inclusion criteria”, “Critical appraisal”, “Data extraction”, 
“Potential effect modifiers/reasons for heterogeneity”, 
“Data synthesis and presentation” describe the protocol 
for the systematic review.
Systematic map
Article screening and study inclusion criteria
Using the reference management software  Zotero®, all 
exported articles and documents will be organized into 
separate collections, one for each disease. Once the 
searches completed (one per disease and per database), 
references for each search will be archived in a unique 
database, and duplicates will be removed.
Articles retrieved by the bibliographic search will be 
screened as detailed below to keep only those relevant 
for the map. An additional step of eligibility (detailed in 
the “Eligibility criteria” section of the “Systematic review” 
part of the protocol), will be performed to select the sub-
set of articles included in the synthesis.
Screening strategy
The screening of titles, abstracts and full-texts will be 
performed by 3 members of the review team. Eligibility 
criteria have been proposed by the review team and vali-
dated by the expert panel.
Consistency checking
Prior to the beginning of the screening, the 3 persons 
from the review team will screen the titles of 42 articles 
(3 per disease) randomly extracted from those retrieved 
by the search equation. The Kappa scores should be 
larger than 0,6. Differences in screening decisions will be 
discussed, the eligibility criteria refined, and the screen-
ing test performed on 42 different articles, with the aim 
at improving the Kappa scores, if needed.
The same exercise will be conducted on 28 abstracts (2 
per disease).
At the full-text stage, a double-checking of all articles 
rejected will be performed by the project leader.
Eligibility criteria
Different eligibility criteria will be applied at the 3 steps 
of the screening: title, abstract, and full-text. If the infor-
mation provided by the title or abstract is not enough 
to reject or retain the article with certainty, it will be 
retained and examined at the next eligibility stage.
Title
Inclusion criteria: presence of the name of the disease 
or of the pathogen agent responsible for this disease, 
or presence of a generic term related to infectious dis-
eases or pathogens (to ensure we do not reject relevant 
papers when the title is not precise enough). In the case 
of vector-borne diseases, the title may not contain any of 
the above criteria but would still be eligible if it contains 
the name of the vector or a generic term related to vec-
tors (e.g. mosquitoes, ticks, vectors). The list of patho-
gen agents and vectors identified for each disease can be 
found in Additional file 1.
Exclusion criteria: absence of the above-mentioned ele-
ments; or indication that the article is a review, a meta-
analysis, an opinion paper, ex situ studies or theoretical 
modelling. Relevant reviews and meta-analysis will be 
kept in a separate collection for use in the discussion of 
our work.
Abstract
Inclusion criteria: presence of words related to ecosystem 
components, functioning, or management.
Exclusion criteria: similar as for title or elements show-
ing that the paper is a descriptive study (no exposure/
intervention, no comparator); destructive intervention 
targeted towards a vector or a host; intervention non-
related to ecosystems, such as individual prophylaxis, 
micro-habitats removal (tires, flower pots), spraying of 
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organic insecticides, genetical modifications of vectors, 
etc.
Full text
Inclusion criteria: the outcome has been obtained from 
field data (e.g. vector/host collection on the field, epide-
miological database collected in hospitals); presence of 
all PECO elements detailed in the section “Definition of 
the question components”.
Exclusion criteria: similar to those applied for title or 
abstract screening, or elements informing that the out-
come is the output of a model, or has been obtained ex 
situ (e.g. in laboratory).
Reasons for exclusion
The list of articles excluded at full-text will be provided, 
with reason for their exclusion.
Study validity assessment
Critical appraisal will be limited to the identification 
of research design, but susceptibility to bias will not be 
assessed. The type and diversity of research designs will 
be reported in the narrative synthesis accompanying the 
systematic map. We expect to find research designs such 
as: post hoc surveys, cross-sectional studies, time-series, 
and maybe a few before-after studies.
Data coding strategy
Meta-data extraction for mapping will be performed 
by the 3 members of the review team. Meta-data will 
be extracted from all articles retained after the screen-
ing process. From the full-text of these articles, we will 
extract and store in an Excel database the following 
information:
• Title
• First author
• Year of publication
• Country
• Continent
• Disease
• Study design
• Type of ecosystem component/function
• Outcome measured in vector (yes/no)
• Outcome measured in intermediate host (yes/no)
• Outcome measured in non-human final host (yes/
no)
• Outcome measured in human (yes/no)
In the “Country” column, the name of the country/
countries in which field study was performed or data col-
lected will be written. Studies performed at the global 
scale will be attributed the code “global”.
For the name of the disease, the coding will follow the 
list presented in the section Question components.
We will code study designs as follow: PH for post hoc 
surveys, CS for cross-sectional studies, TS for time-
series, and BA for before-after studies.
We expect to describe ecosystem components/func-
tion with the following list established during scoping: 
predation, competition, dilution (includes host species 
richness/diversity), host density/abundance, community 
composition, landscape composition, landscape struc-
ture, habitat type, vegetation measurement (NDVI,   % 
of vegetation cover), habitat perturbation, distance to 
habitat, habitat management. This list may be revised as 
appropriate if other components/functions are identified 
during examination at full-text.
To facilitate the use of the map, epidemiological out-
comes will be coded in 4 different columns, signaling 
where measurements have been conducted.
Study mapping and presentation
The systematic map will be reported as an Excel spread-
sheet. A geographical map will present for each disease 
the geographical distribution of publications. Then, we 
will analyse for each disease the characteristics of publi-
cations per type of ecosystem component/function (i.e. 
Exposure), and per type of epidemiological measurement 
(i.e. Outcome). These results will be presented in tables 
(one per disease) to highlight knowledge gaps and trends 
in research orientations, and as a narrative description.
Systematic review
Study inclusion criteria
From the systematic map table, we will identify group(s) 
of at least 2 articles that have in common a) the same dis-
ease AND b) the same ecosystem component/function 
(listed in the “Data coding” section). Within each group, 
we will perform critical appraisal and metadata extrac-
tion, and synthesize the outcome.
Articles that are not part of any group will be only 
reported in the systematic map section.
Critical appraisal
Critical appraisal strategy
Each study included in synthesis will be critically 
appraised. Expert consultation allowed us to identify and 
prioritize criteria for critical appraisal. As this can vary 
between diseases, one critical appraisal grid will be pro-
duced for each disease, and presented as an additional 
file to the final manuscript. Each of these grids will list 
the different aspects of the studies that need to be con-
sidered to estimate the risk of bias considering the spe-
cificities of each disease. It will be composed of elements 
related to both internal and external validity. Each study 
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will be assessed against each criterion and will obtain a 
high, medium/high, medium/low or low rank regarding 
its risk of bias. We will present these grids in the system-
atic review (see also criteria in section below).
Critical appraisal used in synthesis
Results from papers with a low and medium/low risk of 
bias will be synthesized first. We will report whether they 
are consistent or heterogeneous and hypothesis will be 
made regarding reasons for heterogeneity. Results from 
studies with a medium/high risk of bias will be examined 
subsequently to determine whether they are consistent 
with results from papers with a low and medium/low risk 
of bias and convene extra possible explanations for het-
erogeneity. Studies with an unclear or high risk of bias 
will be excluded of the synthesis, unless they compose 
the majority of the relevant literature. In this case, the 
emphasis will be put on the reasons why biases are high 
and how to possibly remediate to this in future research. 
The list of papers with a high risk of bias will be provided 
with reasons for their exclusion.
Critical appraisal criteria
The grid that will be used to critically appraise each study 
may list the following elements:
A. To assess internal validity:
• Duration of the study: Many diseases that have one 
or several animal hosts in their cycle show a marked 
inter-annual variation due to population dynam-
ics, masting etc. Post-intervention/exposure effects 
might also take some time before being measur-
able, or at the contrary be very transient and disap-
pear quickly. We will thus consider that long studies 
would increase the sustainability of results, although 
measurements could have more chance to be affected 
by variations of the environment independent of the 
intervention/exposure initially examined.
• Distance between replicates of between treatment 
and control: depending of the biology of each disease, 
a “buffer distance” between replicates or between 
treatment and control sites might be relevant and 
established. Trade-off with the interest of having 
replicates in the same ecosystem, to ensure having 
similar conditions, will be discussed with the expert 
panel.
• Study design: before-after intervention/exposure 
studies may be obtained although we do not expect 
to find BACI-designs. We expect to find mostly lon-
gitudinal studies, cross-sectional studies, and possi-
bly time-series.
• Randomization: may be found when choosing sam-
pling plots.
• Sampling methodology: here we will examine how 
the intervention(s)/exposure(s) has been described, 
the outcomes(s) measured, and elements of robust-
ness will be established by the expert panel.
• Accuracy of measurements: replication of measure-
ments or analysis may be a way to minimize errors or 
hazardous results.
• Potential effect modifiers: we will assess if they have 
been identified and/or accounted for (see details in 
“Potential effect modifiers/reasons for heterogene-
ity”).
B. To assess external validity:
• Replications in sites with contrasted conditions (e.g. 
intervention performed in different regions) would 
be highly valuable.
Biases identified and/or reported by the authors of the 
articles will be added to this list when reading papers at 
full-text stage, if considered relevant for our question.
Consistency checking
Prior to beginning the critical appraisal, 2 persons from 
the review team will evaluate a sample of 5 randomly-
extracted articles, using the same critical appraisal grid. 
We will discuss potential differences, and if necessary 
refine the grid and repeat the exercise on 5 new articles.
Data extraction
Meta‑data extraction and coding strategy
Groups or articles studying the same disease and the 
same ecosystem component/function will be identified 
from the map, and submitted to critical appraisal. Then, 
meta-data extraction for synthesis will be performed 
by the 3 members of the review team. Meta-data will 
be extracted from articles with a low, medium/low and 
medium/high risk of bias.
The same data extraction table will be used for all dis-
eases, but reporting will be limited to variables that are 
relevant to each disease (for instance, not reporting vec-
tor-related information for non-vector-borne diseases). 
Below are listed the meta-data that will be extracted, 
related to the context of studies, and the PECO ele-
ments. This list will be implemented during a meeting of 
the expert panel that will take place prior to meta-data 
extraction.
Context 
• Country, city
• GPS coordinates of study site
• Temperate/tropical climate
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• Publication date
Population 
• Type of ecosystem
• Type(s) of habitat(s)
• Pathogen(s)
• Vector(s)
• Host(s)
• Ecosystem component/function
• Ecosystem-related variables measured (abundance, 
diversity, richness…)
• Taxonomic group in which the measure was made 
(i.e. rodents, birds, known hosts, predators, one par-
ticular species…)
• Data collection (on field, from database)
Intervention/exposure 
• Description of the intervention
• Description of the exposure
• Date of the intervention/exposure
Comparator 
• Type of study design
• Duration of follow-up (if before/after or time series)
• Number of sites
• Number of replicates per site
• Distance between sites, between replicates
Outcome 
• Date of outcome measurements
• Measured epidemiologic variable (incidence, preva-
lence, transmission…)
• Species (human, vector, host)
• Number of individuals tested for infection
• Protocol for vector collection or sampling (stage (lar-
vae, nymph, adult), with/without human bait))
• Method used to test for infection
• Ratio of females/males for mosquitoes and sand-flies
• Source of human epidemiologic data (field measures, 
hospital data, national database…)
Data extraction strategy
Data will be extracted from the narrative or figures/tables 
of each article. Priority will be given to primary datasets if 
considered useful for subsequent analysis, or to descrip-
tive statistics (means, medians, standard deviations).
Approaches to missing data
In the case of missing meta-data, NA will be mentioned 
in the table. Missing data will be reported as such if they 
represent an attrition bias.
Consistency checking
The 3 members of the review team will read the same 
5 articles and fill the same meta-data extraction grid. 
Results will be compared, and the grid refined if needed. 
A random sample of 20 studies will be double-checked by 
the project leader.
Potential effect modifiers/reasons for heterogeneity
We will identify the potential effect modifiers in order to 
better understand the different effects that a similar man-
agement option could have in different studies.
We anticipate that these potential effects modifiers will 
be very important for certain diseases that have a very 
large geographical area, thus occurring in extremely vari-
ous ecosystems, and that can infect or be vectored by dif-
ferent species.
• Study location
• Climatic conditions
• Non-biological changes associated with intervention/
exposure (change in temperature, shadow, hydrologi-
cal micro-conditions…)
• Time and period of specimen collection for vectors/
hosts in relation with their known daily and seasonal 
activity.
• Type of ecosystem
• History of the ecosystem (past modifications etc.)
• Time since intervention, in the case of before/after 
study design.
• Socio-economical context (proximity with animals 
(potential hosts such as rodents, but also zooprophy-
laxis), use of prophylaxis…)
• For zoonoses affecting livestock: breeding practices 
(size of herds, breeds, transhumance, veterinary sur-
veillance and treatments…)
Data synthesis and presentation
Type of synthesis
The synthesis will focus on the subset of diseases for 
which relevant literature is available and allows for criti-
cal appraisal. This review will mostly be presented as a 
narrative synthesis with confidence levels.
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Narrative synthesis strategy
The eligible literature will be synthesized in a narrative 
format including confidence levels based on the quality 
assessment of each article. Contradictory results will be 
resumed, with an attempt to provide an explanation of 
the reason(s) for their differences.
Quantitative synthesis strategy
We do not expect to have enough compatible datasets 
(i.e. enough publications studying the same disease, the 
same ecosystem component, and the same outcome) to 
perform meta-analysis.
Qualitative synthesis strategy
As mentioned in the “Eligibility criteria” section, we 
will only retrieve articles in which the outcome has 
been measured and is thus quantitative. Qualitative 
outcomes, such as a change in the perceived risk of dis-
ease by a population are not eligible. Thus, we do not 
expect to find any qualitative data in this review.
Assessment of risk of publication bias
The risk of publication bias is taken in account by look-
ing for grey literature directly on institutional websites, 
and for unpublished articles through solicitation of 
experts.
Knowledge gap identification strategy
Identification of knowledge gaps will be conducted at 
various stages of the review: once literature is screened 
and mapped, absence of articles related to Population, 
Intervention/Exposure or Outcome may be reported. 
During the narrative synthesis, gaps in research designs 
or specific measurements (including that of biases) 
might be highlighted as well.
Demonstrating procedural independence
The screening process will be done by 3 members of the 
review team that have no particular expertise on any of 
the 14 diseases and are not author or co-author of any 
article potentially retrieved by the bibliographic search. 
Experts will join the review process once the screening 
is completed, to participate to the extraction of meta-
data and the critical appraisal.
Additional files
Additional file 1. Names of the I) diseases, II) pathogen agents, and III) 
vector species.
Additional file 2. Test lists, and number of articles from the test lists 
retrieved by the bibliographic search.
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